Famciclovir News
US federal appeals court temporarily stops Teva from selling its generic version of the Novartis medicine Famvir
US Court of Appeals for the Federal Circuit issues order prohibiting Teva from selling its generic version
Bell’s palsy usually a mild condition
Although it sounds exotic, Bell’s palsy isn’t all that rare, occurring in 1 of every 4,000 adults per year. Although sounds very serious, it’s usually a mild condition. Caused by the inflammation of the facial, or seventh,...
TAP Enters Into Co-Promotion Agreement for Famvir(R)
Co-Promotion of Genital Herpes Drug Expands Company's Product Offerings, Leverages Vast Experience in Women's Health
USFDA Approved sNDA for Novartis Pharma Corp.’s Antiviral Agent Famvir®
Novartis Pharmaceuticals Corporation's sNDA for Famvir® (famciclovir) tablets has been approved by the USFDA as a single-day treatment for immunocompetent patients with recurrent genital herpes (RGH).
Novartis gets FDA OK for new Famvir indications
The FDA has approved prescription Novartis' Famvir tablets as a single-day treatment for immunocompetent patients with recurrent genital herpes, based on a supplemental new drug application.